US Generic Injectables Market Analysis, Top Companies, New Technology, Demand and Opportunity

-

The latest report by IMARC Group, titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, finds that the US generic injectables market reached a value of US$ 10.7 Billion in 2017, growing at a CAGR of more than 9% during 2010-2017. Generic injectables are used as an alternative to innovator injectables without compromising the effectiveness of the treatment. They are available in the market only after the expiry of the innovator injectables. Generic injectables are extensively used for treating numerous life-threatening and chronic diseases such as cardiovascular diseases, respiratory diseases, diabetes, rheumatoid arthritis, cancer, osteoporosis and osteoarthritis. They are less expensive than their branded counterparts, thereby contributing in substantial savings for the patients and healthcare providers.

Request to get the sample report: https://www.imarcgroup.com/us-generic-injectables-market/requestsample

Highlights of the US generic injectables market:
  • Expiry of branded injectables is expected to drive the growth of the market in the coming years.
  • The majority of generic injectables are distributed through hospitals.
  • On the basis of therapeutic area, oncology generic injectables account for the majority of the market share.
The US generic injectables market is being driven by numerous favourable factors. Due to sedentary lifestyles, poor eating habits and ageing population, an increasing number of people are suffering from various chronic diseases. As the treatment of these diseases depends on the use of generic injectables for improved effectiveness and cost savings, this has facilitated the growth of the market. Moreover, several branded injectables worth billions of dollars are projected to lose their patent protection in the coming years. This is expected to provide ample opportunities to the generic manufacturers so as to expand their business. Further, the low cost of generic injectables makes them an affordable healthcare option, owing to which the US government is supporting the production of these drugs. Besides this, the low competition in the market results in increased profit margins for the manufacturers. On account of these factors, the market is projected to reach a value of US$ 17.5 Billion by 2023.

The market has been analysed on the basis of therapeutic area where oncology represents the largest segment, followed by anaesthesia, anti-infectives, parenteral nutrition and cardiovascular diseases. On the basis of containers, vials dominate the market, accounting nearly two-thirds of the total share. Vials are followed by ampoules, premix and prefilled syringes. On the basis of distribution channel, hospitals account for the majority of the total sales, followed by retail pharmacy. After analysing the competitive landscape, it is found that the key players operating in the market include Hospira (Pfizer), Hikma, APP (Fresenius Kabi), Sagent, Sandoz (Novartis) and Henry Shein.

Explore Related Research Reports: https://www.imarcgroup.com/us-generic-injectables-market

The report has examined the US generic injectables market on the basis of:

Therapeutic Area:
  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Parenteral Nutrition
  • Cardiovascular
Containers:
  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes
Distribution Channel:
  • Hospitals
  • Retail Pharmacy
Key Players:
  • Hospira (Pfizer)
  • Hikma
  • APP (Fresenius Kabi)
  • Sagent
  • Sandoz (Novartis)
  • Henry Shein
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 

ContactUs

IMARCGroup
USA:+1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Location: Atlanta, GA, USA

Comments

Post a Comment

Popular posts from this blog

European Frozen Seafood Market is Projected to witness Strong Growth during the Forecast Period

-
Image
According to the latest report by IMARC Group, titled “ European Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ”, the  European frozen seafood market  reached a value of US$ 21.4 Billion in 2018, growing at a CAGR of 3.7% during 2011-2018. The European continent is intricately linked with the sea and seafood products form a quintessential part of the regional cuisine. These products serve as a rich source of proteins, micronutrients and essential fatty acids, and are low in fat. They are known to promote heart health, ease the symptoms of arthritis, maintain healthy eyesight, and preserve skin moisture, along with offering innumerable other health benefits. As these products are highly perishable, they require freezing for extending their shelf-life. The freezing process employs advanced techniques like cryofreezing to freeze the products below 200? C. This helps in sealing the flavor and nutrients in the food products fo...
Read more

Xylitol Market to Reach US$ 1,225 Million by 2025 , Industry Overview, Growth Rate and Forecast

-
As per the latest report by IMARC Group, titled “ Xylitol Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025 ”, the  global  xylitol market   size  reached US$ 875 Million in 2019. Xylitol is a sugar alcohol with a crystalline and granular structure and sweetness, which is comparable to sucrose. Also known as wood sugar, it is derived from xylose that occurs naturally in various fruits and vegetables. On a commercial scale, xylitol can be produced by chemical and biotechnological processes. With the rising health-consciousness, consumers are willing to spend more on natural sweeteners, such as xylitol, as it has around 75% fewer carbohydrates and 40% lesser calories as compared to table sugar. Request for a free sample copy of this report:  https://www.imarcgroup.com/xylitol-market/requestsample Global Xylitol Market Trends: Xylitol finds applications in numerous industries ranging from food and beverage (F&B...
Read more

$ 533.4 Billion Warehousing and Storage Market - Driving Factors, Key Players and Growth Opportunities by 2024

-
Image
According to the latest report by IMARC Group, titled “ Warehousing and Storage Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ”, the  global warehousing and storage market size  reached US$ 397.3 Billion in 2018. A warehouse refers to a storage space that is used for stocking finished and semi-finished goods, raw materials, and import and export products. Warehousing and storage services help manufacturers in protecting the goods from pests and insects as well as ensuring a smooth flow of production and distribution activities. At present, the demand for these services is experiencing a rise on account of factors such as the evolving e-commerce sector, the growing popularity of frozen food items and the emerging trend of outsourcing warehousing services. Request for a free sample copy of this report:   https://www.imarcgroup.com/warehousing-and-storage-market/requestsample Global Warehousing and Storage Market Trends: ...
Read more